EP2902016A1 — Febuxostat tablet
Assigned to Alfred E Tiefenbacher GmbH and Co KG · Expires 2015-08-05 · 11y expired
What this patent protects
The present invention relates to a tablet containing febuxostat in crystalline form, which is prepared by granulation. The tablet contains the intragranular and extragranular pharmaceutical excipients in a specific weight ratio, and optionally a surfactant.
USPTO Abstract
The present invention relates to a tablet containing febuxostat in crystalline form, which is prepared by granulation. The tablet contains the intragranular and extragranular pharmaceutical excipients in a specific weight ratio, and optionally a surfactant.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.